Karlsen TH - Search Results

1

Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.

Åberg F, Gissler M, Karlsen TH, Ericzon BG, Foss A, Rasmussen A, Bennet W, Olausson M, Line PD, Nordin A, Bergquist A, Boberg KM, Castedal M, Pedersen CR, Isoniemi H. Åberg F, et al. Among authors: karlsen th. Hepatology. 2015 Feb;61(2):668-77. doi: 10.1002/hep.27538. Epub 2015 Jan 5. Hepatology. 2015. PMID: 25266201

2

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: karlsen th. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

3

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.

Karlsen TH, Lie BA, Frey Frøslie K, Thorsby E, Broomé U, Schrumpf E, Boberg KM. Karlsen TH, et al. Gastroenterology. 2006 Sep;131(3):781-7. doi: 10.1053/j.gastro.2006.05.057. Gastroenterology. 2006. PMID: 16952547

4

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

5

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A, Schrumpf E, Thorsby E, Lie BA. Karlsen TH, et al. J Hepatol. 2007 May;46(5):899-906. doi: 10.1016/j.jhep.2007.01.032. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17383044

6

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms.

Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA. Melum E, et al. Among authors: karlsen th. Hepatology. 2008 Jan;47(1):90-6. doi: 10.1002/hep.21964. Hepatology. 2008. PMID: 18023027

7

An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis.

Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM. Melum E, et al. Among authors: karlsen th. Am J Gastroenterol. 2008 Apr;103(4):1045; author reply 1045-6. doi: 10.1111/j.1572-0241.2007.01772_5.x. Am J Gastroenterol. 2008. PMID: 18397431 No abstract available.

8

Gallbladder polyps in primary sclerosing cholangitis: not so benign.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Curr Opin Gastroenterol. 2008 May;24(3):395-9. doi: 10.1097/MOG.0b013e3282f5727a. Curr Opin Gastroenterol. 2008. PMID: 18408471 Review.

9

[Liver transplantation in Norway through 25 years].

Scholz T, Karlsen TH, Sanengen T, Schrumpf E, Line PD, Boberg KM, Jörgensen PF, Fosby B, Bentdal O, Ostensen AB, Osnes S, Riddervold F, Haugaa H, Hausken J, Bergmann JB, Foss S, Björo K, Foss A; Levertransplantasjonsgruppen ved Oslo universitetssykehus, Rikshospitalet. Scholz T, et al. Among authors: karlsen th. Tidsskr Nor Laegeforen. 2009 Dec 17;129(24):2587-92. doi: 10.4045/tidsskr.09.1106. Tidsskr Nor Laegeforen. 2009. PMID: 20029553 Free article. Norwegian.

10

Update on primary sclerosing cholangitis.

Karlsen TH, Schrumpf E, Boberg KM. Karlsen TH, et al. Dig Liver Dis. 2010 Jun;42(6):390-400. doi: 10.1016/j.dld.2010.01.011. Epub 2010 Feb 20. Dig Liver Dis. 2010. PMID: 20172772 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page